The stock's fall snapped a two-day winning streak.

With talk about the sell-off of Thermo Fisher Scientific’s TMO shares by institutional investors and company insiders, market sentiment toward the company seems bearish. The stock has lost 12.7% in ...

Thermo Fisher Scientific's valuation multiples offer potential capital appreciation. Learn why TMO stock is a Buy, with ...

Thermo Fisher Scientific Inc.’s TMO strategic buyouts and partnerships are poised to help it grow in the upcoming quarters. The company continues to prioritize its partnership with customers to drive ...

Thermo Fisher Scientific Inc (TMO) stock saw a modest uptick, ending the day at $537.23 which represents a slight increase of $7.87 or 1.49% from the prior close of $529.36. The stock opened at ...

Shares of Thermo Fisher Scientific Inc. TMO advanced 1.63% to $529.36 Friday, on what proved to be an all-around mixed ...

In a report released on December 8, Conor McNamara from RBC Capital maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.14% of ...

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-two ratings firms that are presently covering the firm, ...

The US Food and Drug Administration granted clearances to tests for infectious diseases, drug resistances, and chronic diseases, among other clearances.

The GeneTitan® family of instruments and proven GeneChip® Array Plates from Thermo Fisher Scientific are the first to provide a hands-free, automated solution for monitoring gene expression and ...